Q-I have had a terrible time with soreness and aches in my arms and legs. I tried aspirin and other pain medicines, but they don`t work. My doctor says it isn`t the arthritis I thought I had, but ...

UPPER NYACK, N.Y., November 14, 2024--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) is excited to present innovative and transformative research at the American College of Rheumatology ...

Please provide your email address to receive an email when new articles are posted on . “Giant cell arteritis is a heterogeneous disorder with a variety of recognized clinical presentations,” Robert ...

Both polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) present with a broad spectrum of clinical manifestations and almost exclusively occur in the population aged over 50 years. After ...

Q: Please inform your readers about polymyalgia rheumatica. I thought I was experiencing arthritis, until my doctor informed me otherwise. A: Polymyalgia rheumatica is a common disorder that generally ...

RAYOS approved for key rheumatology indications such as Rheumatoid Arthritis, Polymyalgia Rheumatica, Psoriatic Arthritis and Ankylosing Spondylitis. "We are extremely pleased the FDA has approved ...

Background: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. DONOHUE: Both my shoulders started to hurt about a month ago. I ...

Dear Doctor: Please inform your readers about polymyalgia rheumatica. I thought I was experiencing arthritis, until my doctor informed me otherwise. Dear Reader: Polymyalgia rheumatica is a common ...

Arthritis is a problem associated with joints, in which a person suffers from red, hot, swollen and functionally impaired joints. Rheumatoid arthritis is a type of arthritis that is caused due to loss ...

DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- Horizon Pharma, Inc., (NASDAQ: HZNP) announced today that the U.S. Food and Drug Administration (FDA) has approved RAYOS ® (prednisone) delayed-release ...